Profile drafts: Difference between revisions

From QIBA Wiki
Jump to navigation Jump to search
mNo edit summary
mNo edit summary
Line 1: Line 1:
Short Title: QIBA DRAFT Profile: SPECT dopamine transporters


*[[Media:001.QIBA_SPECT_Profile.v0.1_BEZ_2016.02.16_pre-tcon-2_NOedits.docx | QIBA DRAFT Profile: Quantifying Dopamine Transporters with 123-Iodine Labeled Ioflupane in Neurodegenerative Disease - {with stats input - Dr. Obuchowski}]] ''February 16, 2016''
*[[Media:001.QIBA_SPECT_Profile.v0.1_BEZ_2016.02.16_pre-tcon-2_NOedits.docx | QIBA DRAFT Profile: Quantifying Dopamine Transporters with 123-Iodine Labeled Ioflupane in Neurodegenerative Disease - {with stats input - Dr. Obuchowski}]] ''February 16, 2016''
Line 4: Line 6:
*[[Media:001.QIBA_SPECT_Profile.v0.1_BEZ_2016.02.16_pre-tcon-2.docx | QIBA DRAFT Profile: Quantifying Dopamine Transporters with 123-Iodine Labeled Ioflupane in Neurodegenerative Disease {comments - Dr. Zimmerman}]] ''February 16, 2016''
*[[Media:001.QIBA_SPECT_Profile.v0.1_BEZ_2016.02.16_pre-tcon-2.docx | QIBA DRAFT Profile: Quantifying Dopamine Transporters with 123-Iodine Labeled Ioflupane in Neurodegenerative Disease {comments - Dr. Zimmerman}]] ''February 16, 2016''


*[[Media:001 QIBA_SPECT_Profile v0 1 JCD 2016 01 21.docx| QIBA DRAFT Profile: Quantifying Dopamine Transporters with 123-Iodine Labeled Ioflupane in Neurodegenerative Disease (Short Title: QIBA DRAFT Profile: SPECT dopamine transporters)]] ''January 22, 2016''
*[[Media:001 QIBA_SPECT_Profile v0 1 JCD 2016 01 21.docx| QIBA DRAFT Profile: Quantifying Dopamine Transporters with 123-Iodine Labeled Ioflupane in Neurodegenerative Disease {Dr. Seibyl}]] ''January 22, 2016''

Revision as of 15:30, 18 February 2016